Concepedia

Publication | Open Access

Randomized, double-blind, placebo-controlled, parallel-group trial of sirolimus for tocilizumab-resistant idiopathic multicentric Castleman disease

10

Citations

18

References

2020

Year

Abstract

This study was registered with the Japan Registry of Clinical Trials as jRCT2071190029 on October 8, 2019.

References

YearCitations

Page 1